Stefan Lethagen

Papers

1

Total Citations

30

H-Index

1

About

Stefan Lethagen is a leading hematologist whose research has fundamentally advanced the diagnosis and management of von Willebrand disease (VWD), the most common inherited bleeding disorder. His key contributions center on improving diagnostic accuracy for VWD, particularly through the validation of rapid, reliable laboratory assays. Lethagen played a pivotal role in the European multicenter study MCMDM-1VWD, where his work on validating the von Willebrand factor latex immunoassay (VWF-LIA) provided a robust, quantitative tool for diagnosing type 1 VWD, directly impacting clinical practice by enabling faster and more consistent patient identification. His research has garnered significant attention, with his most cited work accumulating over 30 citations, reflecting its influence on standardizing VWD diagnostics. Beyond this, Lethagen has contributed extensively to understanding bleeding disorders, coagulation factor deficiencies, and the optimization of hemophilia care. His dedication to evidence-based hematology and collaborative international research has made him a respected figure in the field, helping to shape modern approaches to bleeding disorder diagnosis and patient management.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD
30 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 15

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago